Hyptis dilatata
Hyptis dilatata · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Hyptis dilatata is a versatile botanical species recognized for its significant range of pharmacological activities. Research indicates that this plant possesses potent antibiotic and anthelmintic properties, making it useful in combating various pathogens. Furthermore, it has demonstrated potential as an anti-HIV agent and acts as a 5-lipoxygenase inhibitor to modulate inflammation. The plant also exhibits cytostatic effects, which are of particular interest in studies regarding cellular growth regulation. These diverse biological functions highlight its importance in the ongoing exploration of natural medicinal compounds.
- Synonyms
- Mesosphaerum Dilatatum · Hyptis Crenata Var. Augustifolia · 1 more
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Hyptis dilatata is a botanical species that is frequently identified by various taxonomic synonyms in scientific literature. One such recognized variation is documented as Hyptis crenata var. augustifolia. Additionally, the plant has been historically classified under the name Hyptis lanicephala. Researchers also refer to this species through its synonym Mesosphaerum dilatatum. Understanding these shifting names is essential for maintaining clarity in botanical studies and plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Hyptis dilatata is a fascinating specimen belonging to the diverse kingdom Plantae. This plant is categorized under the class Equisetopsida, showcasing its unique evolutionary placement. Within this group, it is classified under the order Lamiales, which helps define its structural characteristics. It further belongs to the family Lamiaceae, a group often recognized for its aromatic qualities. Finally, it is identified by its specific genus, Hyptis, which distinguishes it from other related species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Hyptis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Hyptis dilatata maintains a widespread presence across much of the tropical regions in the Americas. Its distribution spans significantly through South America, with extensive coverage found throughout Brazil, including its northern, southeastern, and west-central territories. The plant also thrives in Central America, specifically within the borders of Panamá. Furthermore, its range extends into Northern South America, where it is notably documented in Guyana. This broad geographic footprint highlights the species' ability to adapt to diverse environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Hyptis dilatata is characterized by its distinct growth form as a herbaceous plant. This species is entirely self-supporting, allowing it to maintain its structure naturally within its habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Hyptis dilatata has emerged as a plant of significant pharmacological interest due to its diverse biological activities. Research conducted in the Brazilian Amazon demonstrates that its essential oils possess potent anthelmintic properties, specifically showing inhibitory effects against the nematode Caenorhabditis elegans. Beyond its antiparasitic potential, studies involving Venezuelan medicinal plant extracts have highlighted the species' medicinal versatility. Specifically, Hyptis dilatata has demonstrated notable cytostatic activity when tested against various tumor cell lines. These combined findings suggest that the plant holds great promise for further development in both antiparasitic and antitumor therapeutic research.
Compounds
Conditions
Hyptis dilatata demonstrates significant cytostatic activity according to recent screening of Venezuelan medicinal plant extracts. During a study involving 308 extracts, this specific species was identified as one of the plants exhibiting the greatest potential for inhibiting cell growth. This biological activity was measured against a panel of six different tumor cell lines using a 24-h sulphorhodamine B assay. The findings highlight the plant's effectiveness in treating tumor cells through cytostatic mechanisms rather than purely cytotoxic ones. These results serve to confirm previous reports and encourage more extensive research into the plant's medicinal properties.